Alliancebernstein L.P. Xenon Pharmaceuticals Inc. Transaction History

Alliancebernstein L.P.

$261 Billion
Q1 2025

A detailed history of Alliancebernstein L.P. transactions in Xenon Pharmaceuticals Inc. stock. As of the latest transaction made, Alliancebernstein L.P. holds 1,329,386 shares of XENE stock, worth $41.8 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

1,329,386

Previous 1,443,180 7.88%

Holding current value

$41.8 Million

Previous $56.6 Million 21.16%

% of portfolio

0.02%

Previous 0.02%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$33.55 - $40.74 $3.82 Million - $4.64 Million	-113,794 Reduced 7.88%	1,329,386 $44.6 Million
Q4 2024 Feb 12, 2025	BUY	$38.14 - $45.74 $703,492 - $843,674	18,445 Added 1.29%	1,443,180 $56.6 Million
Q3 2024 Nov 14, 2024	SELL	$36.12 - $43.96 $2.11 Million - $2.57 Million	-58,431 Reduced 3.94%	1,424,735 $56.1 Million
Q2 2024 Aug 14, 2024	BUY	$36.25 - $43.75 $533,600 - $644,000	14,720 Added 1.0%	1,483,166 $57.8 Million
Q1 2024 May 14, 2024	SELL	$42.66 - $50.04 $4.53 Million - $5.31 Million	-106,122 Reduced 6.74%	1,468,446 $63.2 Million
Q4 2023 Feb 14, 2024	BUY	$28.7 - $46.46 $14.1 Million - $22.8 Million	490,231 Added 45.21%	1,574,568 $72.5 Million
Q3 2023 Nov 14, 2023	BUY	$34.16 - $39.73 $34.8 Million - $40.5 Million	1,018,321 Added 1542.54%	1,084,337 $37 Million
Q2 2023 Aug 15, 2023	SELL	$34.84 - $43.54 $1.46 Million - $1.83 Million	-41,946 Reduced 38.85%	66,016 $2.54 Million
Q1 2023 May 15, 2023	BUY	$33.46 - $40.35 $1.71 Million - $2.06 Million	51,127 Added 89.96%	107,962 $3.86 Million
Q4 2022 Feb 14, 2023	SELL	$33.06 - $39.43 $2.84 Million - $3.39 Million	-85,891 Reduced 60.18%	56,835 $2.24 Million
Q3 2022 Nov 15, 2022	SELL	$30.79 - $39.82 $8.84 Million - $11.4 Million	-287,234 Reduced 66.8%	142,726 $5.15 Million
Q2 2022 Aug 15, 2022	BUY	$25.44 - $35.16 $1.36 Million - $1.87 Million	53,309 Added 14.15%	429,960 $13.1 Million
Q1 2022 May 13, 2022	BUY	$25.09 - $33.13 $2.07 Million - $2.73 Million	82,553 Added 28.07%	376,651 $11.5 Million
Q4 2021 Feb 14, 2022	BUY	$15.6 - $35.4 $483,522 - $1.1 Million	30,995 Added 11.78%	294,098 $9.19 Million
Q3 2021 Nov 10, 2021	BUY	$14.86 - $19.45 $3.61 Million - $4.73 Million	243,195 Added 1221.59%	263,103 $4.02 Million
Q2 2021 Jul 30, 2021	BUY	$16.81 - $20.0 $334,653 - $398,160	19,908 New	19,908 $371,000

Others Institutions Holding XENE

# of Institutions

219

Shares Held

69.9M

Call Options Held

444K

Put Options Held

207K

View Full List

About Xenon Pharmaceuticals Inc.

Ticker XENE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,263,500
Market Cap $1.96B
Description
Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...

More about XENE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.

Account

Alliancebernstein L.P. Xenon Pharmaceuticals Inc. Transaction History